The DOJ’s Antitrust Division announced updates late last week to its Civil Investigative Demand (CID) form, explicitly codifying its intent to potentially use materials received in response to CIDs to launch secondary...more
9/20/2020
/ Antitrust Division ,
Antitrust Provisions ,
Antitrust Violations ,
Civil Investigation Demand ,
Corporate Counsel ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
Fifth Amendment ,
Risk Mitigation ,
Securities and Exchange Commission (SEC)
On February 25, 2019, the Third Circuit held that the Federal Trade Commission cannot bring litigation in federal court based on past conduct, absent factual allegations demonstrating that a defendant “is violating or is...more
3/4/2019
/ Administrative Proceedings ,
Administrative Remedies ,
Anti-Competitive ,
Antitrust Violations ,
Appeals ,
Corporate Counsel ,
Disgorgement ,
Dismissals ,
Federal Pleading Requirements ,
Federal Trade Commission (FTC) ,
FTC Act ,
Generic Drugs ,
Illegal Profits ,
Injunctive Relief ,
Lack of Authority ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Remedies ,
Restitution ,
Unfair Competition
The U.S. Court of Appeals for the Second Circuit affirmed a grant of summary judgment on July 19, 2018, in favor of defendants in a nearly decade-old case alleging an unlawful conspiracy in the single-copy magazine industry....more
8/8/2018
/ Antitrust Conspiracies ,
Antitrust Litigation ,
Appeals ,
Boycotts ,
Corporate Counsel ,
Determination on Remand ,
Discovery ,
Dismissals ,
Evidence ,
Expert Reports ,
Magazines ,
Publishers ,
Reaffirmation ,
Retailers ,
Reversal ,
Sherman Act ,
Summary Judgment ,
Wholesale